Hydroxyapatite-mineralized metal-organic frameworks as sonosensitizer modulate tumor microenvironment to potentiate high-intensity focused ultrasound therapy
Bone-derived hydroxyapatite-mineralized metal-organic frameworks as sonosensitizer as sonosensitizer co-encapsulated Zn2+, hypoxic-activated prodrug AQ4N, and STING agonist SR-717 for acoustic-immunological synergistic therapy for acoustic-immunological synergistic therapy improves ablation efficiency and treats residu...